Australian herbal products Limited

According to the treatment and Drug Administration (TGA), in the process of recertification of governing regulations, Australian herbal products have highlighted more than 30 safety review regulations for herbal products Thirty herbal products that have not been classified have been given priority review by OCM and CMEC The other 156 botanical drugs have been reviewed in terms of their dosage and preparation methods, 98% of which are considered to be OK The other 58 have been downgraded to two categories: deregistration of therapeutic drugs in Australia Only suitable homeopathy can be used Local use only requires further review and confirmation Although many of these botanical drugs are applicable to drugs, and the regulatory rules are being further revised, some of them have been recognized by TGA, but the regulatory level of demand is not in place The components of safety inspection of Chinese herbal medicine are re verified by OCM and CMEC, which are part of the extensive review of Chinese herbal medicine regulations in Australia and New Zealand This forms part of the Australian and New Zealand authorities for therapeutic products, but the TGA says the tests are in progress, which is only Australia's view In a recent meeting, the TGA pointed out that the goal of regulatory reform is to provide better clarity and transparency in legislation, because regulators and external interests are relevant Controversial changes include changes under legal supervision: active ingredients supplement drugs designated active ingredients traditional use of herbal homeopathic preparations positive and negative lists will also be published in herbal medicines already on the market In the discussion on the definition of complementary medicine, they emphasized the experience of Canadians, some of which pointed out that some substances, including some that should be defined as complementary medicine but not others, in turn, some that have been defined as complementary medicine but should not be.